Biofarm Ends H1/2026 With 46% Lower Net Profit, 15% Lower Sales Income
Aug 14, 2026
Biofarm Ends H1/2026 With 46% Lower Net Profit, 15% Lower Sales Income.
Drug and supplement producer Biofarm (stock symbol: BIO), which was recently acquired by Polish group Polpharma for RON1.3 billion, had a net (…)
[Read the article in Ziarul Financiar]